Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
about
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsUnlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical ConditionsIsolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantationEffectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027.Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.Prevalence and risk factors for asymptomatic Clostridium difficile carriage.Evaluation of an automated rapid diagnostic test for detection of Clostridium difficile.Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China.Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings.Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model.Estimating risk of C. difficile transmission from PCR positive but cytotoxin negative cases.Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factorsRisk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic ReviewAsymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficileEconomic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation.Effects of control interventions on Clostridium difficile infection in England: an observational study.Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.Control of Clostridium difficile infection in the hospital setting.Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.Optimising gut colonisation resistance against Clostridium difficile infection.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Use of a Perianal Swab Compared With a Stool Sample to Detect Symptomatic Clostridium difficile Infection.Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative.Evolving insights into the epidemiology and control of Clostridium difficile in hospitals.Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection.Diagnosing an Infection Control Risk.Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
P2860
Q28083860-900B9C66-6349-4A86-9442-4C479448FA95Q28546550-7A5ADEBF-7E9D-4733-9A4B-7B9E3439BCD1Q31105341-23B1C33F-B738-4068-9547-FCE8D6B511BEQ33648414-53AC9F43-9AEA-40E9-96BC-EE23579EC426Q33759586-4050314B-C359-43B3-8E6D-047B562E0BEFQ33900157-54C242BF-2EA7-46AE-AB0F-F083C42E47A8Q34048138-49D3B325-C8C3-4527-8E98-C644E31E8413Q34110313-3FC95A02-0D15-426C-A5D5-C6869F8BDB4AQ34667674-18A0B8CA-8AA7-45A2-A955-1845454CD3E2Q34726271-ADAD3C04-A62F-4782-A21F-ABA4402C3233Q34943390-5C6F8251-5771-4C85-A760-CEB275FC2D7BQ35093580-68446FA3-2ECB-4604-850C-F1164FF6F3B3Q35112873-7A2B46E2-01B6-4C6D-A1F5-2BAA92295DC7Q35860076-C4EA1A68-388F-40A4-B979-131839249E92Q36099373-0FEA51BB-A722-4CBA-839A-2D83B4FEE7FCQ36149920-8B797876-5776-4BEA-B5CF-1B878B04ADF7Q36193300-7C7C6F44-B482-4D95-A348-79A5B15AE128Q36726659-E33ABF3C-2E46-49C1-B1DC-B2AE1ECF8C1EQ36977948-2BD82008-0C63-413C-873D-C0BAB5FB2389Q37264328-57BE5A95-1701-4B75-8231-C739CE2D9D10Q37546208-2D261887-3459-45C2-8A08-C1F905319EBAQ37546565-D39B9543-7268-4B38-BB85-1D61C5FCE41BQ37581870-ED267BEF-32A9-40B2-A1FF-255BC371C5CBQ37636055-0C3DCD16-F539-4786-83F9-CD5CCF692FEEQ37723727-A598B51A-EE70-4AFE-B532-AF825B30F0C3Q38162391-EE428067-069B-443D-8A7E-8FD9510642F9Q38192010-5BC2FFAD-7140-43F1-A281-A542471A510BQ38213461-CB83E9AA-BB59-4ADB-92EF-D9BB83E8B99BQ38366858-FF0D96DA-8599-4A58-87AA-91FCC94788F8Q38583798-11AA16C9-76D5-4E40-B656-7F29FB290889Q38765888-4BB1592C-8798-4CEF-A474-B8178F1DEF2CQ38794312-9B4714FF-96AC-46E9-AF75-C749E7FADF3BQ38855057-FF9AB51A-4228-42F4-9AF7-D6CF918AA2A0Q38980670-8505A7BC-0365-4F92-9B99-658D92880516Q39315676-3E7C8BC8-4B03-4768-B060-1B5A8EA65FD2Q40187460-DCFE2690-7207-4641-A34C-A540AE1BEB6EQ40230162-7666DA53-B621-4EB2-9ABD-FEA082BD1168Q40346677-8089ABF3-AC23-4AE9-A8C8-9B8BD974868DQ40375743-9960398C-5CCF-403D-A187-B3C07FFB676BQ40449224-2E1796B2-9A86-4463-96FC-2CD95B22E799
P2860
Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of multilocus variable num ...... ridium difficile transmission.
@en
Use of multilocus variable num ...... ridium difficile transmission.
@nl
type
label
Use of multilocus variable num ...... ridium difficile transmission.
@en
Use of multilocus variable num ...... ridium difficile transmission.
@nl
prefLabel
Use of multilocus variable num ...... ridium difficile transmission.
@en
Use of multilocus variable num ...... ridium difficile transmission.
@nl
P2093
P2860
P356
P1476
Use of multilocus variable num ...... ridium difficile transmission.
@en
P2093
A William Pasculle
Carlene A Muto
Jane W Marsh
Jessica L Schlackman
Kathleen A Shutt
Lee H Harrison
Scott R Curry
P2860
P304
P356
10.1093/CID/CIT475
P407
P577
2013-07-23T00:00:00Z